Anlon Healthcare, a Gujarat-based API and pharma intermediates manufacturer, will debut on the stock exchanges on Wednesday after its Rs 121 crore IPO was subscribed nearly 7 times. Despite strong fundamentals and capacity expansion plans, the grey market premium suggests muted listing gains. Analysts remain optimistic about its long-term growth potential amid rising demand and the “China + 1” supply shift.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets